Blanka Wolszczak Biedrzycka MD,PhD

Phone: 
(+48) 89 524 53 28 (sekretariat)
Publikacje: 

2024 

Biedrzycki G.Wolszczak-Biedrzycka B. U..Michalak D.Żendzian-Piotrowska M.Zalewska A.Maciejczyk M.: The antiglycation potential of H1 receptor antagonists - in vitro studies in bovine serum albumin model and in silico molecular docking analyses: Biomedicine & Pharmacotherapy: 2024, 175, s. 1-15

Wolszczak-Biedrzycka B. U.Dorf J.Matowicka-Karna J.Dymicka-Piekarska V.Wojewódzka-Żeleźniakowicz M.Żukowski P.Zalewska A.Dąbrowski Ł.Maciejczyk M.: Redox Biomarkers - An Effective Tool for Diagnosing COVID-19 Patients and Convalescents: Journal of Inflammation Research: 2024, 17

Wolszczak-Biedrzycka B. U.Dorf J.Matowicka-Karna J.Wojewódzka-Żelezniakowicz M.Żukowski P.Zalewska A.Maciejczyk M.: Significance of nitrosative stress and glycoxidation products in the diagnosis of COVID-19: Scientific Reports: 2024, 14 (1), s. 1-13

2023 

Wolszczak-Biedrzycka B U., Dorf J., Wojewódzka-Żelezniakowicz M., Żendzian-Piotrowska M., Dymicka-Piekarska V., Matowicka-Karna J., Maciejczyk M.: Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study: Frontiers in Immunology: 2023, 14, s. 1-13

Wolszczak-Biedrzycka Blanka U.Dorf JustynaWojewódzka-Żeleźniakowicz MarzenaŻendzian-Piotrowska MałgorzataDymicka-Piekarska ViolettaMatowicka-Karna JoannaMaciejczyk Mateusz (obcy).: Unveiling COVID-19 Secrets: Harnessing Cytokines as Powerful Biomarkers for Diagnosis and Predicting Severity: Journal of Inflammation Research: 2023, 16, s. 6055-6070 

Biedrzycki G.Wolszczak-Biedrzycka B.U., Dorf J.Michalak D.Żendzian-Piotrowska M.Zalewska AnnaMaciejczyk M.: Antioxidant and Anti-Glycation Potential of H2 Receptor Antagonists - In Vitro Studies and a Systematic Literature Review: Pharmaceuticals: 2023, 16 (9), s. 1-19 

Dymicka-Piekarska V.Dorf J.Milewska A.Łukaszyk M.Kosidło J. W.Kamińska J.Wolszczak-Biedrzycka B. U., Naumnik W.: Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR)-Risk of Death Inflammatory Biomarkers in Patients with COVID-19: Journal of Inflammation Research: 2023, 16, s. 2209-2222

Wolszczak-Biedrzycka Blanka U., Dorf J.Milewska A. J.Łukaszyk M.Naumnik W.Kosidło J. W.Dymicka-Piekarska V.: The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality: Journal of Inflammation Research: 2023, 16, s. 2173-2188 

Kosidło J.Wolszczak-Biedrzycka Blanka U., Matowicka-Karna J., Dymicka-Piekarska W., Dorf J..: Clinical Significance and Diagnostic Utility of NLR, LMR, PLR and SII in the Course of COVID-19: A Literature Review: Journal of Inflammation Research: 2023, 16, s. 539-562 

Wolszczak-Biedrzycka B. U.Bieńkowska A.Cieślikiewicz B.Smolińska-Fijołek E., Biedrzycki G., Dorf J.The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection: Annals of Medicine: 2023, 55 (1), s. 722-732 

Wolszczak-Biedrzycka B. U., Bieńkowska A.Zasimowicz E.Biedrzycki G.Dorf J.Jelski W.: An Assessment of the Serum Activity of ADH and ALDH in Patients with Primary Biliary Cholangitis: Archivum Immunologiae et Therapiae Experimentalis: 2023, 71 (2), s. 1-6 

2022

Zasimowicz-Majewska E.Wolszczak-Biedrzycka B. U., Bieńkowska A.: The significance of preanalytical phase in immunohematology testing: International Review of Medical Practice: 2022, 27 (1-2), s. 72-76 

Wolszczak-Biedrzycka B.U., Bieńkowska A.Smolińska-Fijołek E.Biedrzycki G.Dorf J..The Influence of Two Priming Doses of Different Anti-COVID-19 Vaccines on the Production of Anti-SARS-CoV-2 Antibodies After the Administration of the Pfizer/BioNTech BoosterInfection and Drug Resistance: 202215s. 7811-7821 

Wolszczak-Biedrzycka B.U., Bieńkowska A.Zasimowicz E.Biedrzycki G.Dorf J.Jelski WAn Assessment of the Serum Activity of ADH and ALDH in Patients with Primary Biliary CholangitisArchivum Immunologiae et Therapiae Experimentalis2023, 71 (2), s. 1-6 

Wolszczak-Biedrzycka B.U., Bieńkowska A.Maksymowicz S.: Adaptation of medical laboratory scientists to workplace hazards - experiences from the COVID-19 pandemic: Frontiers in Public Health: 2022, s. 1-8 

Wolszczak-Biedrzycka B. U., Bieńkowska A.Zaborowska J. E.Smolińska-Fijołek E.Biedrzycki G.Dorf J.: Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection: Vaccines: 2022, 10 (5), s. 1-12 

Wolszczak-Biedrzycka B. U.Zasimowicz-Majewska E.Bieńkowska A., Biedrzycki G.Dorf J.Jelski W.: Activity of Total Alcohol Dehydrogenase, Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in the Serum of Patients with Alcoholic Fatty Liver Disease: Medicina-Lithuania: 2022, 58 (1), s. 1-11

2021

Wolszczak-Biedrzycka B. U., Bieńkowska A., Dorf J.: Assessment of Post-Vaccination Antibody Response Eight Months after the Administration of BNT1622b2 Vaccine to Healthcare Workers with Particular Emphasis on the Impact of Previous COVID-19 Infection: Vaccines: 2021, 9 (12), s. 1-1

2020

Wolszczak-Biedrzycka B.U., Bieńkowska-Iwanik A.Biedrzycki G.Kloc W.: Badania laboratoryjne jako skuteczne narzędzie oceny niedoborów żywieniowych: International Review of Medical Practice2020, 26 (4), s. 42-46 

Wolszczak-Biedrzycka B.U.Bieńkowska-Iwanik A.Biedrzycki G.Kloc W..: Wpływ tlenku azotu na metabolizm kości: International Review of Medical Practice: 2020, 26 (4), s. 42-45 

2018

Jelski W., Wolszczak-Biedrzycka B.,  Zasimowicz-Majewska E., Orywal K., Piechota J., Lapinski T. W., Bednarczyk M., Szmitkowski M. The Activity of Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in the Sera of Patients with Autoimmune Hepatitis. Clin. Lab. 2018;64:477-481

2017

Wojciech Jelski, Blanka Wolszczak-Biedrzycka, Elżbieta Zasimowicz-Majewska, Karolina Orywal, Tadeusz Wojciech Lapinski and Maciej Szmitkowski. Alcohol DehydrogenaseIsoenzymes and Aldehyde Dehydrogenase Activity in the Serum of Patients with Nonalcoholic Fatty Liver Disease. Anticancer Research.  2017, 38 (7), s. 4005-4009  DOI: 10.21873/anticanres.12688

2014

Wolszczak B., Zasimowicz E.,  Juchniewicz J.: Wpływ alkoholu etylowego na układ endokrynny. Polski Merkuriusz Lekarski 2014; 36, 211, s. 45 - 47 (MNiSW 7 pkt)

Zasimowicz E., Wolszczak B., Zasimowicz B.: Wpływ alkoholu etylowego na patogenezę cukrzycy typu 2. Polski Merkuriusz Lekarski 2014; 36, 213, s. 212 - 214 (MNiSW 7 pkt)